Pathology and ploidy in the prognosis of gastric cancer with no extranodal metastasis

Cancer. 1994 Feb 15;73(4):1127-33. doi: 10.1002/1097-0142(19940215)73:4<1127::aid-cncr2820730402>3.0.co;2-q.

Abstract

Background: The prognostic relevance of morphology in advanced gastric cancer is well known. Data on tumor cell DNA content are still inadequate and contradictory.

Methods: Morphologic parameters and DNA ploidy were evaluated in 76 gastric cancer patients with no extranodal metastases (Stage I, 10 cases; Stage II, 20 cases; and Stage III, 46 cases), using formalin-fixed paraffin-embedded tissue. All cases were followed for at least 6 years after surgery or until death.

Results: Among the potential prognostic factors analyzed by Mantel-Cox and generalized Wilcoxon statistics, male sex (P = 0.02), cardiac location of neoplasia (P = 0.02), deeper infiltration of the gastric wall (P = 0.001), vascular neoplastic invasion (P = 0.006), metastatic lymph nodes (P = 0.001), pathologic stage (P = 0.0001), and aneuploidy (P = 0.01) were significantly associated with lower survival rate. Testing of all of the above-mentioned variables by the Cox stepwise multiple regression model disclosed that factors independently associated with survival were stage (P = 0.0001), ploidy (P = 0.0006), and vascular carcinomatous invasion (P = 0.01).

Conclusions: In gastric cancer with no extranodal metastases, DNA ploidy was found to be the most significant prognostic parameter after pathologic stage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • DNA, Neoplasm / analysis*
  • Female
  • Flow Cytometry
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Ploidies
  • Prognosis
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / mortality*
  • Stomach Neoplasms / pathology*
  • Survival Rate

Substances

  • DNA, Neoplasm